Dr. Rocha is a cardiologist at the Lipid Clinic of Heart Institute (Incor), University of Sao Paulo and Check-up of Fleury Group, Scientific Director of Atherosclerosis Department of Brazilian Society of Cardiology, Doctor in Science, University of Sao Paulo, Brazil, Post-Doctoral fellowship at BWH, Harvard Medical School, USA.

Dr. Rocha has sources of funding and relationships with the following commercial stakeholders in the healthcare sector:

• Aché
• Amgen
• Amryt
• Astra Zeneca
• Biolab
• GSK
• Libbs
• Novartis
• Novo Nordisk
• Roche
• Sanofi